PL2421556T3 - Ulepszona zmodyfikowana żywa szczepionka mycoplasma bovis, sposoby wytwarzania zmodyfikowanych żywych szczepionek mycoplasma bovis, szczepionki skojarzone i sposoby leczenia - Google Patents

Ulepszona zmodyfikowana żywa szczepionka mycoplasma bovis, sposoby wytwarzania zmodyfikowanych żywych szczepionek mycoplasma bovis, szczepionki skojarzone i sposoby leczenia

Info

Publication number
PL2421556T3
PL2421556T3 PL10717367T PL10717367T PL2421556T3 PL 2421556 T3 PL2421556 T3 PL 2421556T3 PL 10717367 T PL10717367 T PL 10717367T PL 10717367 T PL10717367 T PL 10717367T PL 2421556 T3 PL2421556 T3 PL 2421556T3
Authority
PL
Poland
Prior art keywords
vaccines
attenuation
mycoplasma bovis
attenuated mycoplasma
bovis strains
Prior art date
Application number
PL10717367T
Other languages
English (en)
Inventor
Michael Beck
Jeffrey KNITTEL
Original Assignee
Boehringer Ingelheim Vetmedica, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica, Inc. filed Critical Boehringer Ingelheim Vetmedica, Inc.
Publication of PL2421556T3 publication Critical patent/PL2421556T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35Mycoplasma
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL10717367T 2009-04-24 2010-04-23 Ulepszona zmodyfikowana żywa szczepionka mycoplasma bovis, sposoby wytwarzania zmodyfikowanych żywych szczepionek mycoplasma bovis, szczepionki skojarzone i sposoby leczenia PL2421556T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17254309P 2009-04-24 2009-04-24

Publications (1)

Publication Number Publication Date
PL2421556T3 true PL2421556T3 (pl) 2017-09-29

Family

ID=42331013

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10717367T PL2421556T3 (pl) 2009-04-24 2010-04-23 Ulepszona zmodyfikowana żywa szczepionka mycoplasma bovis, sposoby wytwarzania zmodyfikowanych żywych szczepionek mycoplasma bovis, szczepionki skojarzone i sposoby leczenia

Country Status (20)

Country Link
US (1) US9339533B2 (pl)
EP (1) EP2421556B1 (pl)
JP (1) JP5793808B2 (pl)
KR (1) KR101880888B1 (pl)
CN (1) CN102458461B (pl)
AR (1) AR076413A1 (pl)
AU (1) AU2010238689B2 (pl)
BR (1) BRPI1013836B1 (pl)
CA (1) CA2758733C (pl)
CL (1) CL2011002639A1 (pl)
CO (1) CO6460761A2 (pl)
DK (1) DK2421556T3 (pl)
ES (1) ES2630209T3 (pl)
HU (1) HUE033618T2 (pl)
MX (1) MX342443B (pl)
NZ (1) NZ595914A (pl)
PL (1) PL2421556T3 (pl)
SG (2) SG175323A1 (pl)
UY (1) UY32570A (pl)
WO (1) WO2010124154A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008030619A2 (en) * 2006-09-07 2008-03-13 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
AR069087A1 (es) * 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
EP2362780B1 (en) 2008-10-31 2019-12-25 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
WO2011056175A1 (en) * 2009-11-06 2011-05-12 Intervet International B.V. Methods of immunizing pregnant heifers at three months of gestation
CN102294026A (zh) * 2010-11-17 2011-12-28 赤峰博恩药业有限公司 奶牛链球菌乳房炎灭活疫苗及其制备方法
US9175049B2 (en) * 2012-10-24 2015-11-03 The United States Of America, As Represented By The Secretary Of Agriculture Recombinant mycobacterium avium subsp. paratuberculosis proteins induce immunity and protect against infection
JP6370807B2 (ja) 2013-12-18 2018-08-08 旭化成株式会社 乳汁中のストレプトコッカス属の菌を検出する方法
CN103800901B (zh) * 2014-01-27 2015-12-09 内蒙古华希生物科技有限公司 链球菌以及将其灭活得到的奶牛乳房炎疫苗
CN108135989B (zh) 2015-08-14 2022-08-09 硕腾服务有限责任公司 牛支原体组合物
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN107815439A (zh) * 2016-09-14 2018-03-20 华威特(江苏)生物制药有限公司 牛传染性鼻气管炎病毒jsm株及其应用
CN107759674B (zh) * 2017-09-26 2021-12-28 中国农业科学院哈尔滨兽医研究所 一种牛支原体免疫相关性蛋白、含有该蛋白的检测试剂盒及其在牛支原体抗体检测中的用途
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN109847060A (zh) * 2019-04-19 2019-06-07 黑龙江八一农垦大学 牛多杀性巴氏杆菌病、溶血性曼氏杆菌病二联灭活疫苗及其制备方法
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN111733094B (zh) * 2020-05-29 2022-09-09 内蒙古民族大学 一种牛源蜡样芽孢杆菌及其应用
AR124849A1 (es) 2021-02-11 2023-05-10 Intervet Int Bv Vacuna para mycoplasma bovis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8296498A (en) 1997-07-10 1999-02-08 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Method of attenuating pathogenic mycobacteria and strains of mycobacteria so attenuated
EP0965639A1 (en) 1998-06-05 1999-12-22 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
BR0015398A (pt) * 1999-11-08 2002-06-25 Biomune Vacinas para mycoplasma bovis e processos de uso
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
BR0211049A (pt) * 2001-07-02 2004-07-20 Pfizer Prod Inc Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae
US20030147914A1 (en) 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
KR20040031015A (ko) 2001-08-28 2004-04-09 화이자 프로덕츠 인크. 마이코플라즈마 보비스 시험감염 모델, 엠. 보비스 투여방법 및 폐렴성 폐 병변 유도 방법
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
DE102004025452A1 (de) 2004-05-19 2006-01-19 Boehringer Ingelheim Vetmedica Gmbh Vakzine enthaltend BVDV
US20070009545A1 (en) * 2005-07-07 2007-01-11 Joachim Frey Mycoplasma subunit vaccine
WO2008030619A2 (en) 2006-09-07 2008-03-13 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
CN100419073C (zh) * 2006-09-28 2008-09-17 中国兽医药品监察所 猪喘气病活疫苗及其生产方法
US20090068231A1 (en) * 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
CL2008002675A1 (es) * 2007-09-11 2008-11-07 Wyeth Corp Bacteria de mycoplasma gallisepticum atenuada; composicion de vacuna que la comprende; método de vacunación; y método de identificación de clones de mycoplasma gallisepticum atenuados.
AR069087A1 (es) * 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
CA2729080C (en) 2008-07-03 2018-09-11 Ricardo Rosenbusch Cattle vaccines
EP2362780B1 (en) 2008-10-31 2019-12-25 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada

Also Published As

Publication number Publication date
CO6460761A2 (es) 2012-06-15
AR076413A1 (es) 2011-06-08
WO2010124154A1 (en) 2010-10-28
AU2010238689B2 (en) 2017-01-19
CL2011002639A1 (es) 2012-07-20
CA2758733C (en) 2019-12-24
AU2010238689A1 (en) 2011-11-03
JP2012524548A (ja) 2012-10-18
EP2421556A1 (en) 2012-02-29
SG10201401784WA (en) 2014-08-28
SG175323A1 (en) 2011-11-28
HUE033618T2 (en) 2017-12-28
EP2421556B1 (en) 2017-04-05
BRPI1013836B1 (pt) 2020-04-14
KR20120109992A (ko) 2012-10-09
KR101880888B1 (ko) 2018-07-23
CN102458461B (zh) 2017-03-08
DK2421556T3 (en) 2017-07-10
CA2758733A1 (en) 2010-10-28
CN102458461A (zh) 2012-05-16
UY32570A (es) 2010-11-30
US9339533B2 (en) 2016-05-17
MX2011010976A (es) 2011-11-18
NZ595914A (en) 2014-09-26
ES2630209T3 (es) 2017-08-18
JP5793808B2 (ja) 2015-10-14
US20100272759A1 (en) 2010-10-28
MX342443B (es) 2016-09-29

Similar Documents

Publication Publication Date Title
SG10201401784WA (en) Vaccines Comprising Attenuated Mycoplasma Bovis Strains And Method For The Attenuation
EP2554522A4 (en) METHOD FOR REINFORCING A GLASS PAN AND DEVICE THEREFOR
GB2484921B (en) Communications device and method
GB2470072B (en) Entertainment device,system and method
GB2470073B (en) Entertainment device, system and method
ZA201300966B (en) Method for selecting an iinterlayer for vibroacoustic damping, interlayer and glazing unit comprising such an interlayer
EP2577890A4 (en) MULTI-CAPTURE OTDR PROCESS AND DEVICE
PL2534426T3 (pl) Układ do odkażania oraz sposób
EP2598065A4 (en) Device and method for pulmonary vein isolation
EP2724869A4 (en) STRUCTURE, STRUCTURE FORMING METHOD, AND STRUCTURE FORMING DEVICE
EP2476996A4 (en) PARALLAX CALCULATION METHOD AND PARALLAX CALCULATION DEVICE
PL2422693T3 (pl) Urządzenie i sposób przeprowadzania co najmniej jednej funkcji medycznej
EP2398892A4 (en) LIVING WEARED VACCINES
IL226027A0 (en) Two-way text checker and method
PT2724036T (pt) Componente para absorção e/ou transmissão de forças mecânicas e/ou de momentos, método para a sua produção e utilização
ZA201001740B (en) Attenuated mycoplasma gallisepticum strains
GB2469565B (en) Attenuated Francisella bacterium
EP2586748A4 (en) DEVICE FOR PRODUCING FRESH WATER AND METHOD FOR PRODUCING FRESH WATER
EP2521360A4 (en) SENDING DEVICE, TRANSMISSION PROCEDURE, RECEPTION DEVICE AND RECEPTION PROCEDURE
EP2395779A4 (en) METHOD, DEVICE AND SYSTEM FOR PRE-AUTHENTICATION
EP2491946A4 (en) ADJUVANT FOR VACCINES, VACCINES COMPRISING SAME, AND USES THEREOF
GB0901795D0 (en) Medical device and method
EP2660271A4 (en) POLYCARBONATE POLYSILOXAN COPOLYMER AND METHOD FOR THE PRODUCTION THEREOF
EP2544423A4 (en) SENDING DEVICE, SENDING METHOD AND SENDING SYSTEM
EP2455282A4 (en) HIGH-SPEED GENERATOR, WING AND NOISE REDUCTION STRUCTURE FOR THE HIGH-SPEED GENERATOR